Skip to main content

Optinose seeking $40M from stock sale to advance drug-device combo product

The company is working on getting a second approval for its flagship product.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.